“…In general, colicins are directed against both commensal and pathogenic E. coli strains, except for colicin Js, which is active against enteroinvasive E. coli, just as Shigella strains (28,65). Although the precise general role of colicins in the human gut is unknown, there is increasing evidence for bacteriocin-enhanced E. coli colonization of the gastrointestinal tract (21), for the role of colicins in bacterial virulence (e.g., colicin E1 [62]), and for colicin's role in the probiotic phenotype of E. coli strains (14,63).…”